Cantor Fitzgerald reissued their overweight rating on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. Cantor Fitzgerald also issued estimates for Soleno Therapeutics’ FY2023 earnings at ($2.44) EPS and FY2024 earnings at ($1.25) EPS. Separately, Oppenheimer restated an outperform rating and set […]
Zynex (NASDAQ:ZYXI – Free Report) and Soleno Therapeutics (NASDAQ:SLNO – Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Volatility and Risk Zynex has a beta of 0.57, suggesting […]
Oppenheimer reissued their outperform rating on shares of Soleno Therapeutics (NASDAQ:SLNO – Get Rating) in a report published on Friday, Benzinga reports. Oppenheimer currently has a $8.00 target price on the stock. Oppenheimer also issued estimates for Soleno Therapeutics’ FY2027 earnings at $4.09 EPS. Soleno Therapeutics Stock Performance Shares of Soleno Therapeutics stock opened at […]
Analysts expect that Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) will announce ($0.07) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Soleno Therapeutics’ earnings. Soleno Therapeutics posted earnings per share of ($0.14) in the same quarter last year, which indicates a positive year-over-year […]